Mirugen
PrivateLast Round
Seed
Aug 14, 2025
Total Funding Raised
$4.55M
Company Overview
Mirugen operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Seed round in August 2025.
Mirugen is a biotechnology company developing gene therapy to treat blindness by reprogramming cells to unlock innate cellular repair mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirugen Comparables
Compare Mirugen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 78% | |
| Life Biosciences | 77% | |
| SparingVision | 76% |
For institutional investors. Book with your work email.
Mirugen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 14, 2025 | ||||
| Grant | Dec 23, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mirugen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| ANDHealth | Grant |
| Brandon Capital | Seed |
| Tin Alley Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2025
$3M round led by Brandon Capital, genesispsf, and Tin Alley Ventures.
- Dec 23, 2024
$1.27M grant round led by CUREator.
For institutional investors. Book with your work email.
Mirugen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mirugen's valuation, stock price, and market status.
Is Mirugen a public or private company?
Mirugen is a private company.
What is the current stock price of Mirugen?
Mirugen is a private company, so its shares have no public market price. Caplight tracks Mirugen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mirugen worth (valuation)?
Valuation information for Mirugen is not publicly available.
Can I buy Mirugen stock?
Mirugen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mirugen's last funding round?
Mirugen's most recent funding round was Seed on August 14, 2025.
Who are the main investors in Mirugen?
Key investors in Mirugen include CUREator, Brandon Capital, Tin Alley Ventures.
Will Mirugen IPO soon?
No public IPO plans have been announced for Mirugen.
How can I track Mirugen secondary market activity?
Caplight tracks bids, offers, and trades in Mirugen's shares on secondary markets.